Search

everythinglearnresearchcommunity

for

Search:↓

A genetic mutation caused severe rickets and alopecia in an Indian patient, but high-dose calcium and phosphate treatment improved their condition.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Father's finasteride use may affect son's fertility and testicular function.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Early balding at 40 increases prostate cancer risk.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Vitamin D levels do not affect the risk of developing alopecia areata.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Oestrogens are key for bone growth during puberty in both boys and girls.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Melanin may help melanoma cells grow by aiding their metabolism.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

New regenerative therapies show promise for treating hair loss.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.